HALOPERIDOL - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for haloperidol and what is the scope of patent protection?
Haloperidol
is the generic ingredient in six branded drugs marketed by Ortho Mcneil, Ortho Mcneil Pharm, Actavis Group, Aiping Pharm Inc, Aurobindo Pharma Ltd, Chartwell Rx, Duramed Pharms Barr, Innogenix, Lederle, Mankind Pharma, MSN, Mylan, Par Pharm, Purepac Pharm, Quantum Pharmics, Royce Labs, Sciegen Pharms Inc, SCS, Strides Pharma, Upsher Smith Labs, Watson Labs, Zydus Pharms Usa, Janssen Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Meitheal, Mylan Labs Ltd, Sandoz, Somerset Theraps Llc, Teva Pharms Usa, Zydus Pharms, Alpharma, Lannett Co Inc, Morton Grove, Pharm Assoc, Rubicon, Teva, Teva Pharms, Abraxis Pharm, Baxter Hlthcare Corp, Epic Pharma Llc, Fosun Pharma, Marsam Pharms Llc, Sagent Pharms, Smith And Nephew, Solopak, and Actavis Mid Atlantic, and is included in one hundred and twelve NDAs. Additional information is available in the individual branded drug profile pages.There are twenty drug master file entries for haloperidol. Twenty-three suppliers are listed for this compound.
Summary for HALOPERIDOL
US Patents: | 0 |
Tradenames: | 6 |
Applicants: | 49 |
NDAs: | 112 |
Drug Master File Entries: | 20 |
Finished Product Suppliers / Packagers: | 23 |
Raw Ingredient (Bulk) Api Vendors: | 122 |
Clinical Trials: | 219 |
Patent Applications: | 7,034 |
Drug Prices: | Drug price trends for HALOPERIDOL |
Drug Sales Revenues: | Drug sales revenues for HALOPERIDOL |
What excipients (inactive ingredients) are in HALOPERIDOL? | HALOPERIDOL excipients list |
DailyMed Link: | HALOPERIDOL at DailyMed |
Recent Clinical Trials for HALOPERIDOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | Phase 4 |
Christian Hassager | Phase 3 |
Qilu Pharmaceutical Co., Ltd. | Phase 3 |
Pharmacology for HALOPERIDOL
Drug Class | Typical Antipsychotic |
Medical Subject Heading (MeSH) Categories for HALOPERIDOL
Anatomical Therapeutic Chemical (ATC) Classes for HALOPERIDOL
US Patents and Regulatory Information for HALOPERIDOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sciegen Pharms Inc | HALOPERIDOL | haloperidol | TABLET;ORAL | 071130-003 | May 12, 1987 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Scs | HALOPERIDOL | haloperidol | TABLET;ORAL | 070723-001 | Jun 10, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Royce Labs | HALOPERIDOL | haloperidol | TABLET;ORAL | 071723-001 | Dec 24, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | HALOPERIDOL | haloperidol | TABLET;ORAL | 071572-001 | Jun 3, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abraxis Pharm | HALOPERIDOL | haloperidol lactate | INJECTABLE;INJECTION | 071187-001 | Jan 20, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HALOPERIDOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ortho Mcneil | HALDOL | haloperidol | TABLET;ORAL | 015921-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ortho Mcneil | HALDOL | haloperidol | TABLET;ORAL | 015921-004 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ortho Mcneil | HALDOL | haloperidol | TABLET;ORAL | 015921-005 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ortho Mcneil | HALDOL | haloperidol | TABLET;ORAL | 015921-006 | Feb 2, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ortho Mcneil | HALDOL | haloperidol | TABLET;ORAL | 015921-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.